K-ras alterations in Danish ovarian tumour patients. From the Danish "Malova" Ovarian Cancer study (Q44390222)

2 December 2017

K-ras alterations in Danish ovarian tumour patients. From the Danish "Malova" Ovarian Cancer study (English)

1 reference

2 December 2017

1 reference

8

1 reference

2 December 2017

6

Jens Vuust

1 reference

2 December 2017

Estrid V S Høgdall

1

1 reference

2 December 2017

Claus K Høgdall

2

1 reference

2 December 2017

Jan Blaakaer

3

1 reference

2 December 2017

Lise Christensen

4

1 reference

2 December 2017

Johannes E Bock

5

1 reference

2 December 2017

Eva Glud

7

1 reference

2 December 2017

Danish "Malova" Ovarian Cancer Study

9

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

2 December 2017

1 reference

2 December 2017

89

1 reference

2 December 2017

1

1 reference

2 December 2017

31-36

1 reference

The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis.

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900005-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900005-2

1 reference

7 January 2021

Incidence of P53 and K-ras alterations in ovarian mucinous and serous tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900005-2

7 January 2021

Detection and clinical correlations of ras gene mutations in human ovarian tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900005-2

7 January 2021

Model for the molecular genetic diagnosis of endometrial cancer using K-ras mutation analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900005-2

7 January 2021

Simple preparation method of PCR fragments for automated DNA sequencing

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900005-2

7 January 2021

Prognostic significance of ras/p21 alterations in human ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900005-2

7 January 2021

Point mutation of the ras oncogene in human ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900005-2

7 January 2021

Genetic alterations on chromosome 17 distinguish different types of epithelial ovarian tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900005-2

7 January 2021

Alteration of the p53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900005-2

7 January 2021

k-ras mutation may be an early event in mucinous ovarian tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900005-2

7 January 2021

ME-PCR for the identification of mutated K-ras in serum and bile of pancreatic cancer patients: an unsatisfactory technique for clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900005-2

7 January 2021

K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900005-2

7 January 2021

10.1016/S0090-8258(03)00005-2

Identifiers

DOI

1 reference

release_5atyu6px5jai5ecbqryrhmnds4

2 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5atyu6px5jai5ecbqryrhmnds4

24 November 2022

mapped directly with Wikidata item

1 reference